Protagenic Therapeutics, Inc.\new Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Protagenic Therapeutics, Inc.\new (PTIX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 208.42 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 208.42K shares, a 97.99% decline year-over-year.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 10.36M shares, a 4908.94% increase year-over-year.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 491.09K shares, a 137.35% increase year-over-year.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 206.91K shares.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 3.38M shares, a 358.93% increase from fiscal 2025.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 736.06K shares.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.92M shares, a 200.96% increase from fiscal 2023.
- Protagenic Therapeutics, Inc.\new antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 2.30M shares, a 22.83% decline from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 208.42K shares 10-Q · filed 2026-08-19 | |||||||
| 2026-03-31 | 3.38M shares 10-K · filed 2026-08-14 | |||||||
| 2025-12-31 | 10.34M shares 10-Q · filed 2026-03-09 | |||||||
| 2025-09-30 | 10.35M shares 10-Q · filed 2025-11-26 | |||||||
| 2025-06-30 | 10.36M shares 10-Q · filed 2026-08-19 | |||||||
| 2025-03-31 | 491.09K shares 10-Q · filed 2025-05-13 | 736.06K shares 10-K · filed 2026-08-14 | ||||||
| 2024-12-31 | 773.95K shares 10-Q · filed 2026-03-09 | 6.92M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 773.95K shares 10-Q · filed 2025-11-26 | 2.90M shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 206.91K shares 10-QT · filed 2025-09-10 | 2.90M shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 206.91K shares 10-Q · filed 2025-05-13 | 2.90M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 2.30M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 2.50M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 2.50M shares 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | 2.50M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 2.98M shares 10-K/A · filed 2024-05-14 | |||||||
| 2022-09-30 | 3.00M shares 10-Q · filed 2023-11-14 | 12.00M shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 3.00M shares 10-Q · filed 2023-08-14 | 12.00M shares 10-Q · filed 2022-08-11 | ||||||
| 2022-03-31 | 3.02M shares 10-Q · filed 2023-05-15 | 12.08M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 3.02M shares 10-K · filed 2023-03-31 | 12.07M shares 10-K · filed 2022-04-07 | ||||||
| 2021-09-30 | 12.31M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 12.87M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 11.63M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 12.08M shares 10-K · filed 2022-04-07 | |||||||
| 2020-09-30 | 10.87M shares 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | 10.07M shares 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | 9.43M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 9.07M shares 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | 8.67M shares 10-Q · filed 2019-11-14 | |||||||
| 2019-06-30 | 8.67M shares 10-Q · filed 2019-08-14 | |||||||
| 2019-03-31 | 8.65M shares 10-Q · filed 2019-05-16 | |||||||
| 2018-12-31 | 8.55M shares 10-K · filed 2020-04-29 | |||||||
| 2018-09-30 | 8.55M shares 10-Q · filed 2019-11-14 | |||||||
| 2018-06-30 | 8.55M shares 10-Q · filed 2018-08-14 | |||||||
| 2018-03-31 | 8.55M shares 10-Q · filed 2018-05-15 | |||||||
| 2017-12-31 | 8.27M shares 10-K · filed 2019-03-29 | |||||||
| 2017-09-30 | 7.31M shares 10-Q · filed 2017-11-13 | |||||||
| 2017-06-30 | 7.21M shares 10-Q · filed 2017-08-08 | |||||||
| 2017-03-31 | 7.21M shares 10-Q · filed 2017-05-15 | |||||||
| 2016-12-31 | 7.18M shares 10-K · filed 2018-04-02 | |||||||
| 2016-09-30 | 9.22M shares 10-Q · filed 2017-11-13 | |||||||
| 2016-06-30 | 17.44M shares 10-Q · filed 2017-08-08 | |||||||
| 2016-03-31 | 15.82M shares 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | 4.88B shares 10-Q · filed 2016-03-11 | 5.11M shares 10-K/A · filed 2017-05-08 | 5.05M shares 10-K · filed 2017-04-18 | |||||
| 2015-09-30 | 4.88B shares 10-Q · filed 2015-11-13 | 4.80M shares 10-Q · filed 2016-11-17 | ||||||
| 2015-06-30 | 4.80M shares 10-Q · filed 2016-08-15 | 4.88B shares 10-K · filed 2015-09-25 | ||||||
| 2015-03-31 | 4.88B shares 10-Q · filed 2015-05-11 | |||||||
| 2014-12-31 | 4.88B shares 10-Q · filed 2016-03-11 | |||||||
| 2014-09-30 | 4.88B shares 10-Q · filed 2015-11-13 | |||||||
| 2014-06-30 | 4.88B shares 10-K · filed 2015-09-25 | |||||||
| 2014-03-31 | 4.88B shares 10-Q · filed 2015-05-11 | |||||||
| 2013-12-31 | 4.60B shares 10-Q · filed 2015-02-06 | |||||||
| 2013-09-30 | 4.60B shares 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | 4.60B shares 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |